PeptideStack
5.2kquestions
20kanswers
220users

Is a GLP-1 receptor agonist at 1 mg/mL stable enough for eight weeks of multi-withdrawal use?

Asked 27 Mar 2024Modified 2.3 years agoViewed 35k times
26

Numbers first: a GLP-1 receptor agonist · 1 mg/mL · eight weeks.

I would rather be corrected now than propagate something wrong.

I am specifically not interested in a testimonial; I am interested in a measurement.

What would count as evidence here, and does it exist?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsbacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

112 questionsshelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

301 questionsendotoxin
endotoxin

Bacterial endotoxin: LAL and kinetic chromogenic methods, how an endotoxin limit is derived from a dose, why endotoxin survives autoclaving, and…

14 questions
shareeditfollowflag
DS
askedDr_Ravi_Selvarajah42k13827 Mar 2024
8Related: the same reasoning applies to the counter-ion question. – m_haraldsen 32 days ago
add a comment

No answers yet

This question has not been answered. It has been viewed 35k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.